Research: CHM evaluation: Transient embryonic hypoxia and teratogenicity with HPTs
Safety Classified by Officially
MHRA assessment of transient embryonic hypoxia and teratogenicity in relation to oral hormone pregnancy tests (HPTs), as considered by the Commission on Human Medicines (CHM).
This file may not be suitable for users of assistive technology.
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/government/publications/chm-evaluation-transient-embryonic-hypoxia-and-teratogenicity-with-hpts
Officially imported this from Commission on Human Medicines’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Commission on Human Medicines — imported from official source
- Official source
- https://www.gov.uk/government/organisations/commission-on-human-medicines.atom ATOM
- Imported
- September 20, 2026 19:53
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/government/publications/chm-evaluation-transient-embryonic-hypoxia-a...